Carsten Brunn Selecta Biosciences Inc (SELB) insider trading activity

SELB Quotes by TradingView

Carsten Brunn is President and CEO of SELECTA BIOSCIENCES INC. Currently has a direct ownership of 4.92 Million shares of SELB, which is worth approximately $4.13 Million. The most recent transaction as insider was on Jan 02, 2024, when has been sold 4,654,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.92M
0% 3M change
1776.67% 12M change
Total Value Held $4.13 Million

Carsten Brunn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
-
4,654,100 Added 48.63%
4,916,056 Common Stock
Nov 13 2023
SELL
Sale (or disposition) back to the issuer
$1,073,517 $2.06 p/Share
521,125 Reduced 66.55%
261,956 Common Stock
Sep 25 2023
SELL
Open market or private sale
$3,107 $1.06 p/Share
2,932 Reduced 0.37%
783,081 Common Stock
Jan 05 2023
SELL
Open market or private sale
$15,224 $1.13 p/Share
13,473 Reduced 1.69%
786,013 Common Stock
Jan 04 2023
SELL
Open market or private sale
$31,460 $1.14 p/Share
27,597 Reduced 3.34%
799,486 Common Stock
Jan 02 2023
BUY
Grant, award, or other acquisition
-
282,800 Added 25.48%
827,083 Common Stock
Dec 05 2022
SELL
Open market or private sale
$6,014 $1.33 p/Share
4,522 Reduced 0.82%
544,283 Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
-
10,938 Added 1.95%
548,805 Common Stock
Sep 28 2022
SELL
Open market or private sale
$4,469 $1.66 p/Share
2,692 Reduced 0.5%
537,867 Common Stock
Sep 02 2022
SELL
Open market or private sale
$8,821 $1.85 p/Share
4,768 Reduced 0.87%
540,559 Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
-
10,937 Added 1.97%
545,327 Common Stock
Jun 01 2022
BUY
Exercise of conversion of derivative security
-
10,938 Added 2.01%
534,390 Common Stock
Mar 02 2022
SELL
Open market or private sale
$9,852 $1.81 p/Share
5,443 Reduced 1.03%
523,452 Common Stock
Mar 01 2022
BUY
Exercise of conversion of derivative security
-
10,937 Added 2.03%
528,895 Common Stock
Jan 05 2022
SELL
Open market or private sale
$42,015 $3.09 p/Share
13,597 Reduced 2.56%
517,958 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
226,300 Added 29.86%
531,555 Common Stock
Dec 10 2021
SELL
Open market or private sale
$51,416 $2.99 p/Share
17,196 Reduced 5.33%
305,255 Common Stock
Dec 08 2021
BUY
Grant, award, or other acquisition
-
37,500 Added 10.42%
322,451 Common Stock
Dec 02 2021
SELL
Open market or private sale
$14,048 $2.96 p/Share
4,746 Reduced 1.64%
284,951 Common Stock
Dec 01 2021
BUY
Exercise of conversion of derivative security
-
10,938 Added 3.64%
289,697 Common Stock
Oct 13 2021
SELL
Open market or private sale
$67,224 $4.39 p/Share
15,313 Reduced 5.21%
278,759 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
-
37,500 Added 11.31%
294,072 Common Stock
Sep 24 2021
BUY
Grant, award, or other acquisition
-
27,200 Added 9.59%
256,572 Common Stock
Sep 02 2021
SELL
Open market or private sale
$20,399 $4.51 p/Share
4,523 Reduced 1.93%
229,372 Common Stock
Sep 01 2021
BUY
Exercise of conversion of derivative security
-
10,937 Added 4.47%
233,895 Common Stock

Also insider at

SURF
Surface Oncology, Inc. Healthcare
Director
CB

Carsten Brunn

President and CEO
Watertown, MA

Track Institutional and Insider Activities on SELB

Follow SELECTA BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SELB shares.

Notify only if

Insider Trading

Get notified when an Selecta Biosciences Inc insider buys or sells SELB shares.

Notify only if

News

Receive news related to SELECTA BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SELB